Related references
Note: Only part of the references are listed.Amyloid-β Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity
Izumi Maezawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
CCR2 Antagonists
Mary Struthers et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Reimagining Alzheimer's Disease-An Age-Based Hypothesis
Karl Herrup
JOURNAL OF NEUROSCIENCE (2010)
Microglia in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Inflammation, microglia, and alzheimer's disease
Brent Cameron et al.
NEUROBIOLOGY OF DISEASE (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Monocyte Chemoattractant Protein-1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease
Anna Sokolova et al.
BRAIN PATHOLOGY (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Systemic inflammation and disease progression in Alzheimer disease
C. Holmes et al.
NEUROLOGY (2009)
CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction
Tomomi Kiyota et al.
PLOS ONE (2009)
Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications
Joseph El Khoury et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease
M Kitazawa et al.
JOURNAL OF NEUROSCIENCE (2005)
Overexpression of monocyte chemotactic protein-1/CCL2 in β-amyloid precursor protein transgenic mice show accelerated diffuse β-amyloid deposition
M Yamamoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Mild cognitive impairment as a diagnostic entity
RC Petersen
JOURNAL OF INTERNAL MEDICINE (2004)
Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients
D Galimbert et al.
ANNALS OF NEUROLOGY (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease
LM Sly et al.
BRAIN RESEARCH BULLETIN (2001)
Share Paper
